Alivus Life Sciences Faces Decline Amid Broader Market Trends and Small-Cap Strength

May 16 2025 10:05 AM IST
share
Share Via
Alivus Life Sciences saw a significant decline on May 16, 2025, following a three-day gain streak. Despite today's drop, the company remains above key moving averages, indicating a longer-term positive trend. Over the past year, it has outperformed the Sensex, showcasing resilience in a volatile market.
Alivus Life Sciences, a midcap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 5.01% on May 16, 2025. This drop comes after a three-day streak of gains, indicating a potential trend reversal. The stock reached an intraday low of Rs 1152.05, reflecting a decrease of 4.49% during the trading session.

In terms of performance metrics, Alivus Life Sciences has underperformed its sector by 4.31% today. However, it remains above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term positive trend despite today's setback.

On the broader market front, the Sensex opened lower, down 138.11 points, and is currently trading at 82,336.22, a decline of 0.24%. The index is still close to its 52-week high, being just 4.42% away from the peak of 85,978.25. In contrast, small-cap stocks are showing strength, with the BSE Small Cap index gaining 0.76% today.

Over the past year, Alivus Life Sciences has demonstrated strong performance, with a 37.34% increase compared to the Sensex's 11.77% rise, highlighting its resilience in a fluctuating market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News